$TPH
Tri Pointe Homes, Inc. Stock $tph

$tph Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000156168023000060 Filed on April 27, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$837.3M	$779.7M
YoY Change	-17.72%	5.9%
Cost Of Revenue	$659.4M	$590.2M
YoY Change	-9.89%	11.13%
Gross Profit	$178.0M	$189.4M
YoY Change	-37.77%	-7.64%
Gross Profit Margin	21.25%	24.3%
Selling, General & Admin	$98.25M	$88.23M
YoY Change	3.04%	9.34%
% of Gross Profit	55.21%	46.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.128M	$7.054M
YoY Change	-9.09%	33.47%
% of Gross Profit	3.44%	3.72%
Operating Expenses	$105.7M	$88.23M
YoY Change	10.8%	9.34%
Operating Profit	$72.31M	$92.33M
YoY Change	-59.31%	-19.72%
Interest Expense	$0.00	$0.00
YoY Change
% of Operating Profit	0.0%	0.0%
Other Income/Expense, Net	$11.09M	$7.604M
YoY Change	9462.93%	2685.35%
Pretax Income	$83.44M	$103.2M
YoY Change	-54.62%	-13.07%
Income Tax	$21.50M	$27.40M
% Of Pretax Income	25.77%	26.55%
Net Earnings	$60.72M	$74.74M
YoY Change	-55.98%	-15.54%
Net Earnings / Revenue	7.25%	9.59%
Basic Earnings Per Share	$0.61	$0.74
Diluted Earnings Per Share	$0.60	$0.73
COMMON SHARES
Basic Shares Outstanding	100.1M shares	101.0M shares
Diluted Shares Outstanding	100.6M shares	101.7M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$981.6M	$966.3M
YoY Change	263.38%	134.14%
Cash & Equivalents	$981.6M	$966.3M
Short-Term Investments
Other Short-Term Assets	$12.71M	$17.96M
YoY Change	3.47%	18.66%
Inventory	$3.193B	$3.142B
Prepaid Expenses
Receivables	$64.96M	$141.1M
Other Receivables	$52.17M	$0.00
Total Short-Term Assets	$4.305B	$4.250B
YoY Change	9.87%	10.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$66.79M	$66.88M
YoY Change	-1.9%	13.84%
Goodwill	$139.3M	$139.3M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$140.0M	$134.1M
YoY Change	6.51%	9.57%
Other Assets	$40.65M	$34.85M
YoY Change	-36.82%	-43.98%
Total Long-Term Assets	$475.8M	$489.5M
YoY Change	-4.16%	1.73%
TOTAL ASSETS
Total Short-Term Assets	$4.305B	$4.250B
Total Long-Term Assets	$475.8M	$489.5M
Total Assets	$4.781B	$4.739B
YoY Change	8.29%	9.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$78.39M	$57.54M
YoY Change	-30.6%	-24.3%
Accrued Expenses	$307.2M	$436.3M
YoY Change	-13.65%	32.82%
Deferred Revenue	$46.71M	$43.44M
YoY Change	-39.91%	-40.94%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$491.4M	$493.8M
YoY Change	-12.78%	-9.12%
LONG-TERM LIABILITIES
Long-Term Debt	$1.380B	$1.379B
YoY Change	3.06%	3.06%
Other Long-Term Liabilities	$12.51M	$12.79M
YoY Change	-47.33%	-45.69%
Total Long-Term Liabilities	$1.392B	$1.379B
YoY Change	2.18%	1.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$491.4M	$493.8M
Total Long-Term Liabilities	$1.392B	$1.379B
Total Liabilities	$1.884B	$1.873B
YoY Change	-2.2%	-1.69%
SHAREHOLDERS EQUITY
Retained Earnings	$2.895B	$2.863B
YoY Change	16.43%	18.92%
Common Stock	$991.0K	$1.002M
YoY Change	-2.75%	-4.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.896B	$2.864B
YoY Change
Total Liabilities & Shareholders Equity	$4.781B	$4.739B
YoY Change	8.29%	9.86%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$60.72M	$74.74M
YoY Change	-55.98%	-15.54%
Depreciation, Depletion And Amortization	$6.128M	$7.054M
YoY Change	-9.09%	33.47%
Cash From Operating Activities	$62.10M	$135.6M
YoY Change	-220.07%	-216.82%
INVESTING ACTIVITIES
Capital Expenditures	$5.944M	$6.501M
YoY Change	-136.98%	-48.19%
Acquisitions
YoY Change
Other Investing Activities	-$5.392M	-$2.951M
YoY Change	-34.09%	-58.68%
Cash From Investing Activities	-$11.34M	-$9.452M
YoY Change	-53.26%	-51.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-35.49M	-$49.55M
YoY Change	-46.72%	-62.75%
NET CHANGE
Cash From Operating Activities	62.10M	$135.6M
Cash From Investing Activities	-11.34M	-$9.452M
Cash From Financing Activities	-35.49M	-$49.55M
Net Change In Cash	15.27M	$76.63M
YoY Change	-110.71%	-128.51%
FREE CASH FLOW
Cash From Operating Activities	$62.10M	$135.6M
Capital Expenditures	$5.944M	$6.501M
Free Cash Flow	$56.15M	$129.1M
YoY Change	-257.53%	-200.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001561680
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssets
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
CY2023Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	1-35796
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Tri Pointe Homes, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	61-1763235
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	940 Southwood Blvd
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Incline Village
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89451
CY2023Q1	dei	City Area Code CityAreaCode	775
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	413-1030
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	TPH
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	100098269	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	966298000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	889664000	usd
CY2023Q1	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	141076000	usd
CY2022Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	169449000	usd
CY2023Q1	us-gaap	Inventory Real Estate InventoryRealEstate	3142412000	usd
CY2022Q4	us-gaap	Inventory Real Estate InventoryRealEstate	3173849000	usd
CY2023Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	134071000	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	129837000	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	156603000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	156603000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	34851000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	34851000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	163929000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	165687000	usd
CY2023Q1	us-gaap	Assets Assets	4739240000	usd
CY2022Q4	us-gaap	Assets Assets	4719940000	usd
CY2023Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	57544000	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	62324000	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	436275000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	443034000	usd
CY2023Q1	us-gaap	Loans Payable LoansPayable	287427000	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	287427000	usd
CY2023Q1	us-gaap	Senior Notes SeniorNotes	1091509000	usd
CY2022Q4	us-gaap	Senior Notes SeniorNotes	1090624000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1872755000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1883409000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	100172227	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100172227	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	101017708	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	101017708	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	1002000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1010000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	0	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3685000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2862621000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2827694000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2863623000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2832389000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	2862000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	4142000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2866485000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2836531000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4739240000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4719940000	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	665000	usd
CY2022Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	646000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	41862000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	32239000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	46366000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48456000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	92331000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	115016000	usd
CY2023Q1	tph	Home Building Income Loss From Equity Method Investments HomeBuildingIncomeLossFromEquityMethodInvestments	227000	usd
CY2022Q1	tph	Home Building Income Loss From Equity Method Investments HomeBuildingIncomeLossFromEquityMethodInvestments	-55000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7604000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	273000	usd
CY2023Q1	tph	Homebuilding Income Loss From Continuing Operations Before Taxes HomebuildingIncomeLossFromContinuingOperationsBeforeTaxes	100162000	usd
CY2022Q1	tph	Homebuilding Income Loss From Continuing Operations Before Taxes HomebuildingIncomeLossFromContinuingOperationsBeforeTaxes	115234000	usd
CY2023Q1	tph	Financial Services Income Loss From Equity Method Investments FinancialServicesIncomeLossFromEquityMethodInvestments	0	usd
CY2022Q1	tph	Financial Services Income Loss From Equity Method Investments FinancialServicesIncomeLossFromEquityMethodInvestments	46000	usd
CY2023Q1	tph	Financial Services Income Loss From Continuing Operations Before Taxes FinancialServicesIncomeLossFromContinuingOperationsBeforeTaxes	3045000	usd
CY2022Q1	tph	Financial Services Income Loss From Continuing Operations Before Taxes FinancialServicesIncomeLossFromContinuingOperationsBeforeTaxes	3490000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	103207000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	118724000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27350000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30225000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	75857000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	88499000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1115000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1021000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	74742000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	87478000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.74
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.82
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.73
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.81
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101019253	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107326911	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101706438	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108197485	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2836531000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	75857000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	232000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	9780000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3861000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	37821000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2395000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	0	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2866485000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2447633000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	88499000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	29000	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	9076000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5272000	usd
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	123090000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2409267000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	75857000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	88499000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7054000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5285000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	227000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3861000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5272000	usd
CY2023Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	717000	usd
CY2022Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	766000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	usd
CY2022Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	2253000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-31965000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	233238000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-28373000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-247000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	429000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1622000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4780000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-8839000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-6752000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	25254000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	135639000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-116114000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6501000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12547000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	2951000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	7141000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9452000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19688000	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	usd
CY2022Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	504000	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2395000	usd
CY2022Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	382000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	232000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	29000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	9780000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	9076000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	37610000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	123090000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-49553000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-133023000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	76634000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-268825000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	889664000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	681528000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	966298000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	412703000	usd
CY2023Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	10	state
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these financial statements requires our management to make estimates and judgments that affect the reported amounts of assets and liabilities and the disclosures of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from our estimates.</span></div>
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents and Concentration of Credit Risk</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define cash and cash equivalents as cash on hand, demand deposits with financial institutions, and short-term liquid investments with a maturity date of less than three months from the date of acquisition, including U.S. Treasury bills and government money-mark funds with maturities of 90 days or less when purchased. The Company’s cash balances exceed federally insurable limits. The Company monitors the cash balances in its operating accounts and adjusts the cash balances as appropriate; however, these cash balances could be impacted if the underlying financial institutions fail or are subject to other adverse conditions in the financial markets. To date, the Company has experienced no loss or lack of access to cash in its operating accounts.</span></div>
CY2023Q1	tph	Number Of Principal Businesses NumberOfPrincipalBusinesses	2	business_line
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	779661000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	736244000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101019253	shares
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	103207000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	118724000	usd
CY2023Q1	us-gaap	Assets Assets	4739240000	usd
CY2022Q4	us-gaap	Assets Assets	4719940000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	74742000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	74742000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	87478000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	87478000	usd
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107326911	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	687185	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	870574	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101706438	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108197485	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.74
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.82
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.73
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.81
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2671754	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2405692	shares
CY2023Q1	tph	Escrow Proceeds And Other Accounts Receivable Net EscrowProceedsAndOtherAccountsReceivableNet	84709000	usd
CY2022Q4	tph	Escrow Proceeds And Other Accounts Receivable Net EscrowProceedsAndOtherAccountsReceivableNet	113082000	usd
CY2023Q1	us-gaap	Insurance Settlements Receivable InsuranceSettlementsReceivable	56367000	usd
CY2022Q4	us-gaap	Insurance Settlements Receivable InsuranceSettlementsReceivable	56367000	usd
CY2023Q1	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	141076000	usd
CY2022Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	169449000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	472000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	472000	usd
CY2023Q1	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	1191754000	usd
CY2022Q4	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	1293681000	usd
CY2023Q1	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1335789000	usd
CY2022Q4	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1279394000	usd
CY2023Q1	us-gaap	Inventory Land Held For Development And Sale InventoryLandHeldForDevelopmentAndSale	158908000	usd
CY2022Q4	us-gaap	Inventory Land Held For Development And Sale InventoryLandHeldForDevelopmentAndSale	140725000	usd
CY2023Q1	tph	Real Estate Inventories Owned Model Homes RealEstateInventoriesOwnedModelHomes	240333000	usd
CY2022Q4	tph	Real Estate Inventories Owned Model Homes RealEstateInventoriesOwnedModelHomes	231157000	usd
CY2023Q1	tph	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Inventory Real Estate Owned BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInventoryRealEstateOwned	2926784000	usd
CY2022Q4	tph	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Inventory Real Estate Owned BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInventoryRealEstateOwned	2944957000	usd
CY2023Q1	us-gaap	Land Under Purchase Options Recorded LandUnderPurchaseOptionsRecorded	215628000	usd
CY2022Q4	us-gaap	Land Under Purchase Options Recorded LandUnderPurchaseOptionsRecorded	228892000	usd
CY2023Q1	tph	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Real Estate Not Owned BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRealEstateNotOwned	215628000	usd
CY2022Q4	tph	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Real Estate Not Owned BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRealEstateNotOwned	228892000	usd
CY2023Q1	us-gaap	Inventory Real Estate InventoryRealEstate	3142412000	usd
CY2022Q4	us-gaap	Inventory Real Estate InventoryRealEstate	3173849000	usd
CY2023Q1	tph	Number Of Projects Transferred To Land Held For Future Development NumberOfProjectsTransferredToLandHeldForFutureDevelopment	2	project
CY2023Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	37479000	usd
CY2022Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	28553000	usd
CY2023Q1	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	37479000	usd
CY2022Q1	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	28553000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	0	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	0	usd
CY2022Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	191411000	usd
CY2021Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	173563000	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	37479000	usd
CY2022Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	28553000	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	20251000	usd
CY2022Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	17065000	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	208639000	usd
CY2023Q1	tph	Variable Interest Entity Deposits At Risk VariableInterestEntityDepositsAtRisk	215628000	usd
CY2023Q1	tph	Variable Interest Entity Remaining Purchase Price VariableInterestEntityRemainingPurchasePrice	1226189000	usd
CY2022Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	185051000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2022Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023Q1	tph	Land Option Abandonments And Pre Acquisition Charges LandOptionAbandonmentsAndPreAcquisitionCharges	717000	usd
CY2022Q1	tph	Land Option Abandonments And Pre Acquisition Charges LandOptionAbandonmentsAndPreAcquisitionCharges	766000	usd
CY2023Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	717000	usd
CY2022Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	766000	usd
CY2023Q1	tph	Variable Interest Entity Consolidated Inventory Held VariableInterestEntityConsolidatedInventoryHeld	0	usd
CY2022Q4	tph	Variable Interest Entity Deposits At Risk VariableInterestEntityDepositsAtRisk	228892000	usd
CY2022Q4	tph	Variable Interest Entity Remaining Purchase Price VariableInterestEntityRemainingPurchasePrice	1340333000	usd
CY2022Q4	tph	Variable Interest Entity Consolidated Inventory Held VariableInterestEntityConsolidatedInventoryHeld	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	139300000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	139300000	usd
CY2023Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	17959000	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	20471000	usd
CY2023Q1	us-gaap	Deposit Assets DepositAssets	7107000	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	5226000	usd
CY2023Q1	us-gaap	Real Estate Held For Development And Sale RealEstateHeldForDevelopmentAndSale	1192000	usd
CY2022Q4	us-gaap	Real Estate Held For Development And Sale RealEstateHeldForDevelopmentAndSale	1192000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	6155000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	6515000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	66880000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	67430000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	63700000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	63918000	usd
CY2023Q1	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	936000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	935000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	163929000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	165687000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	22352000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	60682000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	101527000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	104375000	usd
CY2023Q1	tph	Estimated Cost For Completion Of Real Estate Inventories EstimatedCostForCompletionOfRealEstateInventories	107792000	usd
CY2022Q4	tph	Estimated Cost For Completion Of Real Estate Inventories EstimatedCostForCompletionOfRealEstateInventories	108072000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	43439000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	42027000	usd
CY2023Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	44193000	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	17280000	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	23972000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	9351000	usd
CY2023Q1	tph	Other Tax Liability OtherTaxLiability	2741000	usd
CY2022Q4	tph	Other Tax Liability OtherTaxLiability	4099000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	77472000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	77728000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	12787000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	19420000	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	436275000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	443034000	usd
CY2023Q1	us-gaap	Loans Payable LoansPayable	287427000	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	287427000	usd
CY2022Q4	tph	Number Of Seller Financed Loan NumberOfSellerFinancedLoan	1000	loan
CY2023Q1	tph	Number Of Seller Financed Loan NumberOfSellerFinancedLoan	1000	loan
CY2023Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	37500000	usd
CY2022Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	28600000	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	24000000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	9400000	usd
CY2022Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	usd
CY2023Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	usd
CY2022Q4	us-gaap	Insurance Settlements Receivable InsuranceSettlementsReceivable	56400000	usd
CY2023Q1	us-gaap	Insurance Settlements Receivable InsuranceSettlementsReceivable	56400000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	104375000	usd
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	103976000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	5902000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	4721000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	8750000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	5663000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	101527000	usd
CY2022Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	103034000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	2835000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	2490000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1927000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	83000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3861000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5272000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	32400000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	34900000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	34900000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3400000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3400000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27400000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30200000	usd
CY2022Q1	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	0	usd
CY2023Q1	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	0	usd
CY2023Q1	tph	Interest Paid Capitalized Net InterestPaidCapitalizedNet	-15866000	usd
CY2022Q1	tph	Interest Paid Capitalized Net InterestPaidCapitalizedNet	-17869000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	329000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	259000	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	243000	usd
CY2023Q1	tph	Amortization Of Deferred Loan Costs AmortizationOfDeferredLoanCosts	986000	usd
CY2022Q1	tph	Amortization Of Deferred Loan Costs AmortizationOfDeferredLoanCosts	889000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001561680-23-000060-index-headers.html	Edgar Link	pending
0001561680-23-000060-index.html	Edgar Link	pending
0001561680-23-000060.txt	Edgar Link	pending
0001561680-23-000060-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
q12023tphex101.htm	Edgar Link	pending
q12023tphex102.htm	Edgar Link	pending
q12023tphex103.htm	Edgar Link	pending
q12023tphex311.htm	Edgar Link	pending
q12023tphex312.htm	Edgar Link	pending
q12023tphex321.htm	Edgar Link	pending
q12023tphex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tph-20230331.htm	Edgar Link	pending
tph-20230331.xsd	Edgar Link	pending
tph-20230331_g1.jpg	Edgar Link	pending
tph-20230331_def.xml	Edgar Link	unprocessable
tph-20230331_cal.xml	Edgar Link	unprocessable
tph-20230331_lab.xml	Edgar Link	unprocessable
tph-20230331_pre.xml	Edgar Link	unprocessable
tph-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TPH
Tri Pointe Homes, Inc. Stock $tph

2023 Q2 Form 10-Q Financial Statement

#000156168023000060 Filed on April 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TPH Tri Pointe Homes, Inc. Stock $tph

2023 Q2 Form 10-Q Financial Statement

#000156168023000060 Filed on April 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TPH
Tri Pointe Homes, Inc. Stock $tph